Oncofactor Garners $2,100,000 Series A Financing Round

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    1616 Eastlake Ave. E. Seattle, WA 98102
  • Company Description
    Oncofactor is developing cancer therapeutics that disrupt signaling pathways between tumors and the immune system.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
    Series A
  • Proceeds Purposes
    Specific proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    OVP Venture Partners
  • Venture Investor
    Alexandria Real Estate Equities
  • Venture Investor
    Amgen Ventures
  • Venture Investor
    ARCH Venture Partners
  • Venture Investor
  • Venture Investor
    WRF Capital

Trending on Xconomy